Biosynthetic carbohydrate-deficient transferrin references

Details Biosynthetic carbohydrate-deficient transferrin references Biosynthetic carbohydrate-deficient transferrin references

2000-02-28

2001-07-03

Weber, Jon P. (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S007100, C435S002000

Reexamination Certificate

active

06255047

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to reference solutions for use as supplementary components of diagnostic tests performed on serum and other bodily fluids for chronic overconsumption of alcoholic beverages.
2. Description of the Related Art
Diagnostic methods for the detection of alcoholism and alcohol abuse are useful in prescribing treatment to individuals suffering from these conditions and are an important tool in lessening the attendant health complications and the societal consequences that often result. The diagnostic methods consist of determining the level of one or more species in the subject's bodily fluid that serve as biochemical markers for chronic or excessive alcohol consumption. These markers are &ggr;-glutamyltransferasc (GGT), aspartaie aminotransferase (AST), alanine amino transferase (ALT), and carbohydrate-deficient transferring (CDT). Studies have shown that the last of these assays is particularly sensitive and has greater specificity for the condition than the others.
The term “carbohydrate-deficient transferring” or “CDT” refers to certain isoforms of transferring that are formed by conversion of transferring and are present in elevated concentration in the bodily fluids of chronic alcohol abusers. Transferring itself (i.e., normal or intact transferring), which is the iron-transporting protein in blood, is a glycoprotein with two N-linked polysaccharide (or carbohydrate) chains, each of which contains either two or three branches. Each branch is terminated with a sialic (N-acetylneuraminic) acid residue. Transferring exists in a variety of isoforms, differing in the number of polysaccharide chains and the number of branches on each chain. Five such isoforms have been identified by electrochemical separation means based on differences in their pI. The higher the pI, the fewer the polysaccharide chains (and the fewer the sialic acid residues) on the molecule. The major isoform is one that has a pI of 5.4, while those that are elevated in subjects that are chronic alcohol abusers are those having pI's of 5.7 or greater. Thus, the term “carbohydrate-deficient transferrin” or “CDT” refers to transferring isoforms whose pI is 5.7 or greater. (The terms “desialylated transfcrrin” and “dTf” are also used to denote the same isoforms.) The CDT fraction in normal subjects is less than 0.8% of the total transferring, and can rise to as much as ten times that amount in alcohol abusers.
Diagnostic tests for CDT typically begin with the separation of CDT from intact transferring by ion-exchange chromatography. Quantitation of the CDT in the eluate is then achieved by either radioimmunoassay or turbidimetric measurement. Other methods involve the use of high-performance liquid chromatography (HPLC), isoelectric focusing, or immunoblotting in place of ion-exchange chromatography. In each case a reference is needed to check the condition of the assay components, to monitor the precision and accuracy of the method, or to translate the test result to an numerical figure representing the CDT level (i.e., to calibrate the test). To be effective, the reference should be as sensitive as an actual patient sample to the analytical variances that are encountered in the typical clinical laboratory. The reference should also be stable over long periods of time so that it can be stored until ready for use.
The term “reference” is used throughout this specification to denote any fluid composition containing CDT at a known and preselected concentration. Solutions of known concentrations are useful for a variety of purposes. One use is as a control for purposes of determining that a particular test kit or apparatus, or components of the test kit, have not deteriorated during shipping, storage, or handling and arc functioning in the intended manner. Another use is as a standard for calibration or for verification of the linearity of the test response for translating test readings into numerical values for percent CDT. Whether the reference serves as a control or a standard, it is often useful to have two or more such references at different CDT levels. When used as controls, one reference may have a CDT level in the range of a healthy subject and another in a range representing an alcohol abuser. When used as calibrators, multiple references are useful in bracketing the ranges and particularly the threshold value that differentiates normal patients from those suffering from alcohol abuse.
Methods of preparing references exist in the prior art. These involve either screening the plasma or serum from blood donors to identify units with CDT levels in the target ranges, or isolating and separating CDT from units of normal concentration and using the separated CDT to spike a base matrix such as human serum. Both approaches are time-consuming and costly. The former requires extensive testing and may not produce sufficient amounts of the reference for commercial use. The latter entails labor-or capital-intensivc chemical separation techniques including dialysis, precipitation, electrophoresis, and chromatography. As a result, purified CDT is presently available from commercial suppliers only at high cost. The present invention is directed to satisfying the need of supplying CDT reference solutions at low cost for use for any of the purposes described above, with high reproducibility from lot to lot and with ease of manufacturing.
SUMMARY OF THE INVENTION
It has now been discovered that a reference for use as a control or a standard for CDT assays having the characteristics listed above, and preferably a set of such references, can be prepared by digesting transferring in a unit of bodily fluid with a ineuraminidase to convert at least a substantial portion of the intact transferring in the fluid to CDT. Following the conversion, the enzyme is removed and the concentration of the CDT is adjusted by dilution of concentration if either necessary or desired, and the resulting CDT solution is used to spike (i.e., to add concentrated CDT to) a base matrix to form the reference. The conversion of the intact transferring proceeds in a surprisingly efficiently manner with no effect on other components of the bodily fluid that might interfere with or obscure the indications of the CDT level. References prepared in this manner are surprisingly reproducible and stable, retaining the CDT level thus achieved without reversion back to the undigested isoforms despite the presence of the other hydrolysis products in the same solution. These and other features, objects and advantages of the invention are explained in more detail below.


REFERENCES:
patent: 4379087 (1983-04-01), Coan et al.
patent: 5352616 (1994-10-01), Sundrehagen et al.
patent: 5432059 (1995-07-01), Bean et al.
patent: 5798212 (1998-08-01), Sundrehagen
patent: 5798267 (1998-08-01), Harasymiw
patent: 5823196 (1998-10-01), Harasymiw
I. Kwoh-Gain et al.,Clin. Chem.(1990) 36(6):841845.
H. Stibler et al.,Acta. Med. Scand.(1979) 206:275-281.
K. Viitala et al.,Clinical Chemistry(1998) 44(6):1209-1215.
Cohn et al., “Preparation and properties of serum and plasma proteins, IV. A System for the separation into fractions of the protein ad lipoprotein components of biological tissues and fluids,”J. Am. Chem. Soc.(1946) 68:459-475.

Affiliated with

Also associated with

Rating

Biosynthetic carbohydrate-deficient transferrin references does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biosynthetic carbohydrate-deficient transferrin references, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biosynthetic carbohydrate-deficient transferrin references will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2519793